| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Tuesday’s Close |
|---|---|---|---|---|---|
| IONS | Ionis Pharmaceuticals, Inc. | $48.21 | $6.62B | N/A |
Want to Get in on Biotech? Check Out These 3 Stocks
https://www.fool.com/investing/2017/05/16/want-to-get-in-on-biotech-check-out-these-3-stocks.aspx?source=iedfolrf0000001
May 16, 2017 - These three biotech equities have room to run.
1
Alnylam Pharmaceuticals, Inc. Earnings: All Eyes on APOLLO
https://www.fool.com/investing/2017/05/10/alnylam-pharmaceuticals-inc-earnings-all-eyes-on-a.aspx?source=iedfolrf0000001
May 10, 2017 - Results from the APOLLO clinical trial testing the biotech's lead drug are expected in the September time frame.
1
Why Ionis Pharmaceuticals Inc. Swooned 6% in May
https://www.fool.com/investing/2017/06/06/why-ionis-pharmaceuticals-inc-swooned-6-in-may.aspx?source=iedfolrf0000001
Jun 06, 2017 - Some downbeat news from a Phase 3 trial overshadowed all the good news that was delivered during the month.
1
Alnylam Pharmaceuticals, Inc. Earnings: Waiting for Apollo
https://www.fool.com/investing/2017/08/14/alnylam-pharmaceuticals-inc-earnings-waiting-for-a.aspx?source=iedfolrf0000001
Aug 14, 2017 - Next month's phase 3 data are much more important than the biotech's second-quarter earnings release.
1
Billionaire George Soros' Fund Bought These 3 Pharma Stocks: Should You?
https://www.fool.com/investing/2017/09/18/billionaire-george-soros-fund-bought-these-3-stock.aspx?source=iedfolrf0000001
Sep 18, 2017 - These three orphan drugmakers were on Soros' radar last quarter.
1
Better Buy: Biogen Inc. vs. Celgene
https://www.fool.com/investing/2018/06/03/better-buy-biogen-inc-vs-celgene.aspx?source=iedfolrf0000001
Jun 03, 2018 - Which of these beaten-down biotech stocks wins in a head-to-head match-up?
1
Will Endo (ENDP) Surprise This Earnings Season Again?
http://www.zacks.com/stock/news/226940/will-endo-endp-surprise-this-earnings-season-again?cid=CS-ZC-FT-226940
Aug 04, 2016 - Endo International (ENDP) is set to report second-quarter 2016 results on Aug 8. It posted a positive earnings surprise of 2.86% last quarter.
1
3 Stocks That Growth Investors Should Love
https://www.fool.com/investing/2017/04/23/3-stocks-that-growth-investors-should-love.aspx?source=iedfolrf0000001
Apr 23, 2017 - Impressive growth could be in store for biotech stocks Celgene, Ionis, and Vertex.
1
These 3 Stocks Look Expensive, but Are Actually Cheap
https://www.fool.com/investing/2017/09/29/these-3-stocks-look-expensive-but-are-actually-che.aspx?source=iedfolrf0000001
Sep 29, 2017 - These three stocks prove that you shouldn't judge a book by its cover.
1
CES 2012: Ion Audio's iPad-Integrated Musical Instruments
https://www.wired.com/video/ces-2012-ion-audios-ipad-integrated-musical-i
Jan 09, 2012 - Ion Audio shows off the Piano Apprentice and Guitar Apprentice at CES Unveiled. These instruments feature an iPad dock and light up keys (or frets) that allow even a tone-deaf novice to learn piano, guitar or even drums.
0